UTI Mid Cap Fund Direct Growth
Equity
Direct
Mid-Cap
NAV as on 11-03-2025
₹ 284.59
▲0.3%
1D
Inception Returns
18.4%
/yr
About UTI Mid Cap Fund Direct Growth
UTI Mid Cap Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Ankit Agarwal. The fund could potentially beat inflation in the long-run.
Key Parameters
- UTI Mid Cap Fund Direct Growth has ₹9899 Cr worth of assets under management (AUM) as on Jan 2025 and is less than category average.
- The fund has an expense ratio 0.9.
Returns
UTI Mid Cap Fund Direct Growth has given a CAGR return of 18.39% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 2.79%, 14.80% and 22.66% respectively.
Holdings
UTI Mid Cap Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Consumer Cyclical, Financial Services, Industrial, Basic Materials, Health, Tech, Real Estate, Communication, Consumer Defensive, Utilities. Its top holdings are Coforge Ltd, Phoenix Mills Ltd, Persistent Systems Ltd, Ajanta Pharma Ltd, PB Fintech Ltd
Taxation
As it is a mid-cap mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
Investment objective of UTI Mid Cap Fund Direct Growth
The objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of mid cap companies. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. UTI Mid Cap Fund Direct Growth has no lock in period.
Historical NAV & Returns
Absolute
▲
▼
1885 people have invested ₹ 1.5Cr in UTI Mid Cap Fund Direct Growth in the last three months
INDmoney Rank for UTI Mid Cap Fund Direct Growth
Powered by IND quant engine
17
/19
29% Performance
32% Risk Management
46% Cost
17 out of 19 among mid-cap
Beats FD returns for both 3Y & 5Y
Has not generated consistent returns
Does not beat the benchmark consistently
Higher probablity of downside risk
UTI Mid Cap Fund Direct Growth Overview
| Expense ratio | 0.9% |
Benchmark | S&P BSE Midcap TR INR |
| AUM | ₹9899 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹500 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 36.32% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (11-Mar-25)
Fund Distribution
as on (31-Jan-25)
Mid cap
66.1%
Small cap
20%
Large cap
9.1%
Sector Allocation
Consumer Cyclical
19.1%
Financial Services
19%
Industrial
16.1%
Tech
12.3%
Health
11.9%
Basic Materials
11.3%
Communication
3.5%
Real Estate
3.1%
Consumer Defensive
2.2%
Utilities
1.5%
All changes are between Nov'24 and Jan'25
- AUM of the fund stands at 11.1K Cr as of Jan'25
- AUM decreased by 872.4 Cr between Jan'25 and Dec'24
Top Stocks bought last month
Solar Industries India Ltd's allocation increased from 1.78% to 2.01%
L&T Technology Services Ltd's allocation increased from 0.9% to 1.12%
Muthoot Finance Ltd's allocation increased from 1.48% to 1.69%
Top Stocks sold last month
Coforge Ltd's allocation decreased from 2.73 % to 2.52 %
Persistent Systems Ltd's allocation decreased from 2.36 % to 2.34 %
PB Fintech Ltd's allocation decreased from 2.27 % to 2.13 %
Large Cap allocation has gone up from 6.9% to 7.3%
Small Cap allocation has gone down from 23.1% to 21.7%
Mid Cap allocation has gone up from 67.5% to 67.9%
Cash allocation has gone up from 2.2% to 2.7%
Top 3 Sectors in January were Consumer Cyclical, Financial Services & Industrial
Jan'25
Consumer Cyclical
19%
Financial Services
19%
Industrial
16%
Dec'24
Consumer Cyclical
20%
Financial Services
18%
Industrial
18%
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Coforge Ltd | 2.52% | 0% | |
 Phoenix Mills Ltd | 2.46% | 0% | |
 Persistent Systems Ltd | 2.31% | -1.6% | |
 Ajanta Pharma Ltd | 2.04% | 0% | |
 PB Fintech Ltd | 2.03% | 6% |
See all
Top Growth Drivers | 1M Return |
|---|---|
 Shriram Finance Ltd | 16.2% |
 Gland Pharma Ltd | 14% |
 Cholamandalam Investment & Finance Company Ltd | 8.3% |
Loading...
We are taking more time than usual
Ankit Agarwal
Fund Manager of UTI Mid Cap Fund Direct Growth, since 30 August 2019
Top funds managed
Fund House
UTI Asset Management Co Ltd
Total Schemes
Total AUM
₹2.34L Cr
as on 31-Jan-2025
Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
Phone
+912266786666
Website
pms_care@uti.co.in
Mutual Fund Insights
This fund expense ratio is slightly on the lower side within the category (mid-cap). Its expense ratio is 0.9% which is lower than the category average expense ratio of 1.15%.
Over the last 1 year, this fund has increased expense ratio by 13.9% moving from 0.79 to 0.90.
Over the last 3 months, this fund has experienced a 17.7% drop in AUM moving from 12.02K Cr to 9.89K Cr.
In the last 3 years, Motilal Oswal Midcap Direct Growth has given 29.08% return, outperforming this fund by 14.09% per annum.
In the last 5 years, Quant Mid Cap Fund Growth Option Direct Plan has given 32.05% return, outperforming this fund by 9.58% per annum.
In the last 1 year, Motilal Oswal Midcap Direct Growth has given 15.25% return, outperforming this fund by 13.14%.
UTI Mid Cap Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 18.39% since inception which is less than its category average return of 18.4%
Fund Allocations
This fund has an allocation of 96.44% in Equity, 0% in Debt and 3.56% in Cash related instruments
AUM size ₹9899 Cr
This fund has AUM of ₹9899 Cr which is less than its category average of ₹ 11362 Cr
Expense Ratio 0.9%
This fund has an expense ratio of 0.9% which is less than its category average expense ratio of 1.2%
Frequently Asked Questions for UTI Mid Cap Fund Direct Growth
The current NAV of UTI Mid Cap Fund Direct Growth is ₹284.59 as on 11-Mar-2025.
Existing (Absolute + CAGR) as on 11-Mar-2025.
UTI Mid Cap Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -3.87% | -3.87% |
6 Month Returns | -19.53% | -19.53% |
1 Year Returns | 2.79% | 2.79% |
3 Years Returns | 51.31% | 14.8% |
5 Years Returns | 177.69% | 22.66% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.9% as on February 2025
₹9899 Cr as on February 2025
Coforge Ltd(2.52%), Phoenix Mills Ltd(2.46%), Persistent Systems Ltd(2.31%), Ajanta Pharma Ltd(2.04%), PB Fintech Ltd(2.03%) as on February 2025
Consumer Cyclical(20%), Financial Services(18.89%), Industrial(13.49%) as on February 2025
The alpha ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
UTI Mid Cap Fund Direct Growth | 0.31 | -4.48 | -1.19 |
As on February 2025
The alpha for UTI Mid Cap Fund Direct Growth is calculated against S&P BSE Midcap TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
UTI Mid Cap Fund Direct Growth | 1.08 | 0.93 | 0.89 |
As on February 2025
The Beta for UTI Mid Cap Fund Direct Growth is calculated with S&P BSE Midcap TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
UTI Mid Cap Fund Direct Growth | -0.25 | 0.47 | 0.77 |
As on February 2025
The sharpe ratio for UTI Mid Cap Fund Direct Growth is calculated with S&P BSE Midcap TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
UTI Mid Cap Fund Direct Growth | 20.72 | 16.28 | 20.68 |
As on February 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 0.71 as on February 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Ankit Agarwal is the fund manager of UTI Mid Cap Fund Direct Growth
The Exit load of UTI Mid Cap Fund Direct Growth is 1%